PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1
The review presents current data on the prevalence of diabetes in the cohort of patients undergoing coronary artery bypass grafting and percutaneous coronary intervention. The expediency of a proactive approach to identifying diabetes and pre-diabetes in patients with coronary heart disease before c...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2017-05-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/876 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850029085767499776 |
|---|---|
| author | N. A. Bezdenezhnykh A. N. Sumin O. L. Barbarash |
| author_facet | N. A. Bezdenezhnykh A. N. Sumin O. L. Barbarash |
| author_sort | N. A. Bezdenezhnykh |
| collection | DOAJ |
| description | The review presents current data on the prevalence of diabetes in the cohort of patients undergoing coronary artery bypass grafting and percutaneous coronary intervention. The expediency of a proactive approach to identifying diabetes and pre-diabetes in patients with coronary heart disease before coronary revascularization is reviewed. The current information about the negative impact of diabetes on the prognosis of myocardial revascularization is provided, and the main mechanisms responsible for the development of adverse outcomes of interventions in these patients are highlighted. Target values of perioperative glycemia recommended by the leading communities of the study of diabetes are compared, and shown the role of other carbohydrate metabolism markers (glycated hemoglobin, fructosamine, 1,5-anhydroglucitol) in patients with diabetes mellitus in terms of their impact on cardiovascular prognosis, including with coronary intervention. |
| format | Article |
| id | doaj-art-3aca78140c9b44b588e3102cb5dd353f |
| institution | DOAJ |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2017-05-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-3aca78140c9b44b588e3102cb5dd353f2025-08-20T02:59:38Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202017-05-010410511310.15829/1560-4071-2017-4-105-113789PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1N. A. Bezdenezhnykh0A. N. Sumin1O. L. Barbarash2Research Institute for Complex Issues of Cardiovascular DiseasesResearch Institute for Complex Issues of Cardiovascular DiseasesResearch Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State UniversityThe review presents current data on the prevalence of diabetes in the cohort of patients undergoing coronary artery bypass grafting and percutaneous coronary intervention. The expediency of a proactive approach to identifying diabetes and pre-diabetes in patients with coronary heart disease before coronary revascularization is reviewed. The current information about the negative impact of diabetes on the prognosis of myocardial revascularization is provided, and the main mechanisms responsible for the development of adverse outcomes of interventions in these patients are highlighted. Target values of perioperative glycemia recommended by the leading communities of the study of diabetes are compared, and shown the role of other carbohydrate metabolism markers (glycated hemoglobin, fructosamine, 1,5-anhydroglucitol) in patients with diabetes mellitus in terms of their impact on cardiovascular prognosis, including with coronary intervention.https://russjcardiol.elpub.ru/jour/article/view/876diabetespre-diabetescoronary artery bypass graftingpercutaneous coronary intervention, glycated hemoglobin, fructosamine, 1,5-anhydroglucitol |
| spellingShingle | N. A. Bezdenezhnykh A. N. Sumin O. L. Barbarash PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1 Российский кардиологический журнал diabetes pre-diabetes coronary artery bypass grafting percutaneous coronary intervention, glycated hemoglobin, fructosamine, 1,5-anhydroglucitol |
| title | PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1 |
| title_full | PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1 |
| title_fullStr | PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1 |
| title_full_unstemmed | PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1 |
| title_short | PATIENTS WITH DIABETES AND MYOCARDIAL REVASCULARIZATION FROM EVIDENCE-BASED MEDICINE POSITIONS: CARDIOLOGIST’S OPINION. PART 1 |
| title_sort | patients with diabetes and myocardial revascularization from evidence based medicine positions cardiologist s opinion part 1 |
| topic | diabetes pre-diabetes coronary artery bypass grafting percutaneous coronary intervention, glycated hemoglobin, fructosamine, 1,5-anhydroglucitol |
| url | https://russjcardiol.elpub.ru/jour/article/view/876 |
| work_keys_str_mv | AT nabezdenezhnykh patientswithdiabetesandmyocardialrevascularizationfromevidencebasedmedicinepositionscardiologistsopinionpart1 AT ansumin patientswithdiabetesandmyocardialrevascularizationfromevidencebasedmedicinepositionscardiologistsopinionpart1 AT olbarbarash patientswithdiabetesandmyocardialrevascularizationfromevidencebasedmedicinepositionscardiologistsopinionpart1 |